The Dialysis Patient’s Quality of Life

This flow traces how HCV adds psychological and nutritional burdens to the already restrictive experience of dialysis.

increasingBearing stren­gth in each eventdecreasing

Symptom Overlap

Symptom Overlap Invisible distinction Fatigue, cognitive difficulty, and weakness are common in dialysis whether or not HCV is present. This overlap makes HCV-related suffering easy to overlook. A diagnostic cost When symptoms are attributed only to uremia, the patient’s infection may be treated as a laboratory result rather than an illness affecting daily life.

Mental Burden

Mental Burden Reduced mental well-being Studies associate anti-HCV status with lower mental quality-of-life scores in dialysis. Depression may arise from fatigue, uncertainty, stigma, and fear of long-term liver disease. A hidden outcome The patient’s burden is not captured by viral load or creatinine alone. Treatment decisions should therefore consider the possibility that successful antiviral therapy can improve lived experience even when organ outcomes remain uncertain.

Nutritional Decline

Nutritional Decline Biological and social stress HCV-positive dialysis patients may have lower albumin and altered lipid profiles. Inflammation, reduced appetite, liver disease, and treatment fatigue can converge on nutritional vulnerability. Cardiovascular consequence Malnutrition-inflammation may amplify cardiovascular risk, linking quality of life to survival. The patient’s fate is shaped by a network of small deteriorations rather than one dramatic hepatic event.

during chronic dialysis

after HCV diagnosis

during prolonged dialysis infection